Skip to main content
Checking gut microbiome in cirrhosis may prevent readmission

Evaluating changes to the gut microbiome in patients with cirrhosis identified potential problems and reduced the likelihood the patient would be readmitted, according to a study led by Jasmohan Bajaj, MD, a professor of medicine at Virginia Commonwealth University, that was published in GastroHep. The study used tests ranging from $250 to $650 and found that the more expensive tests resulted in the most overall cost savings.

Full Story: